Georgia Woman Sues Kaiser Permanente After Wrongful Cancer Diagnosis Leads to Unnecessary Hysterectomy

A Georgia woman is pursuing legal action against Kaiser Permanente after hospital staff mistakenly attributed another patient’s tissue sample to her, resulting in an erroneous cancer diagnosis and an unwarranted hysterectomy. Cassandra Barksdale and her legal team filed the lawsuit Tuesday, claiming the administrative error caused her to undergo surgical removal of her uterus on May 15, 2025, and subjected her to months of severe psychological distress.

Barksdale, then 43, visited Kaiser Permanente Southwood Medical Center in Jonesboro in early 2025 seeking care for heavy bleeding and fibroids, benign uterine growths. She underwent a biopsy on March 10, 2025, and received results five days later indicating an aggressive form of endometrial uterine cancer. Based on that diagnosis, she was scheduled for hysterectomy and informed she would require chemotherapy.

In September, a DNA analysis revealed the tissue sample showing aggressive cancer actually belonged to a different patient entirely. Barksdale spent months in a state of distress, even making funeral arrangements with her adult sons in anticipation of her presumed terminal illness. Her attorney Shannan Young stated that each medical decision made afterward was rooted in false information provided by the healthcare system.

Kaiser Permanente acknowledged the error in a statement, saying Barksdale “should not have experienced this” and claiming the organization has implemented additional safeguards to prevent similar incidents. The health system expressed commitment to resolving the matter fairly with Barksdale and her legal representatives. The lawsuit seeks unspecified damages for the harm caused.

Young emphasized that no monetary settlement can restore Barksdale’s healthy organs or undo the emotional trauma she endured. She noted that accountability extends beyond an apology when negligence causes documented harm. Details regarding what occurred with the actual patient whose tissue was mislabeled remain confidential under medical privacy regulations.

Medical sample mix-ups appear to occur sporadically across healthcare systems, though precise frequency data remains limited. An Ohio woman filed a similar suit over a 2019 biopsy error that led to a false lung cancer diagnosis and unnecessary surgery. Researchers identified three cases of biopsy sample misidentification at a prostate cancer facility over a two-year period, according to a 2011 study.

Healthcare laboratories have adopted various prevention strategies including barcode labeling systems and point-of-care testing protocols designed to minimize identification errors during specimen handling and analysis. Despite these measures, instances of sample confusion continue to result in significant patient harm across medical institutions.